In the wake of reports that drugmakers have boosted prices to compensate for agreed-upon discounts in the health care reform legislation, the House Energy and Commerce Committee’s Subcommittee on Health is holding a hearing this morning and you can watch it here, starting at 9:25 am EST (go the lower right corner for the link). If you’re in town, you can stroll over to Room 2123 of the Rayburn House Office Building.

Last month, the House Ways and Means and Energy and Commerce Committees sent a letter to the Government Accountability Office requesting a report on recent trends in prescription drug pricing. The letter also requests that GAO submit a proposal to ensure ongoing monitoring of pricing practices (back story).

Today’s witnesses include Stephen Schondelmeyer, a professor who heads the Department of Pharmaceutical Care and Health Systems at the University of Minnesota, and director of the PRIME Institute; Rick Smith, senior vp for policy, research, and strategic planning at PhRMA; Kathleen Stoll, deputy executive director at Families USA; Bonnie Cramer, board chair at AARP, and John Vernon, a professor at the Department of Health Policy and Management at the University of North Carolina at Chapel Hill, and a Faculty Research Fellow at the National Bureau of Economic Research.